IS7217A - Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum - Google Patents

Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum

Info

Publication number
IS7217A
IS7217A IS7217A IS7217A IS7217A IS 7217 A IS7217 A IS 7217A IS 7217 A IS7217 A IS 7217A IS 7217 A IS7217 A IS 7217A IS 7217 A IS7217 A IS 7217A
Authority
IS
Iceland
Prior art keywords
solvent
polymer compositions
bone growth
modifying compounds
controlled polymer
Prior art date
Application number
IS7217A
Other languages
English (en)
Inventor
Dumont Francis
Wilker Korsmeyer Richard
Li Mei
Madhav Paralkar Vishwas
Lee Dunn Richard
Alexander Jeffers Scott
Zhou Mingxing
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7217A publication Critical patent/IS7217A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
IS7217A 2001-11-30 2004-04-07 Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum IS7217A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33725501P 2001-11-30 2001-11-30
PCT/IB2002/004965 WO2003045351A1 (en) 2001-11-30 2002-11-20 Controlled release polymeric compositions of bone growth promoting compounds

Publications (1)

Publication Number Publication Date
IS7217A true IS7217A (is) 2004-04-07

Family

ID=23319774

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7217A IS7217A (is) 2001-11-30 2004-04-07 Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum

Country Status (35)

Country Link
US (2) US20030104031A1 (is)
EP (1) EP1448166A1 (is)
JP (1) JP4903985B2 (is)
KR (1) KR100629380B1 (is)
CN (1) CN1599598A (is)
AP (1) AP1781A (is)
AR (1) AR037462A1 (is)
AU (2) AU2002347502A1 (is)
BR (1) BR0214610A (is)
CA (1) CA2468703C (is)
DO (1) DOP2002000534A (is)
EA (1) EA011350B1 (is)
EC (1) ECSP045124A (is)
GE (1) GEP20063951B (is)
GT (1) GT200200242A (is)
HR (1) HRP20040486A2 (is)
HU (1) HUP0402135A3 (is)
IL (1) IL161835A0 (is)
IS (1) IS7217A (is)
MA (1) MA27084A1 (is)
MX (1) MXPA04003723A (is)
NO (1) NO20042273L (is)
NZ (1) NZ533115A (is)
OA (1) OA12731A (is)
PA (1) PA8559001A1 (is)
PE (1) PE20030581A1 (is)
PL (1) PL370085A1 (is)
PY (1) PY0229226A (is)
SV (1) SV2004001421A (is)
TN (1) TNSN04096A1 (is)
TW (1) TW200300695A (is)
UA (1) UA76792C2 (is)
WO (1) WO2003045351A1 (is)
YU (1) YU35004A (is)
ZA (1) ZA200402755B (is)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074425B2 (en) * 2002-09-26 2006-07-11 Bonewax, Llc Hemostatic compositions and methods
US20040260398A1 (en) * 2003-02-10 2004-12-23 Kelman David C. Resorbable devices
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
CA2540586A1 (en) * 2003-10-01 2005-04-21 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of aminosugar and uses thereof
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8123787B2 (en) 2004-10-28 2012-02-28 Ogilvie James W Method of treating scoliosis using a biological implant
US8641738B1 (en) 2004-10-28 2014-02-04 James W. Ogilvie Method of treating scoliosis using a biological implant
CA2619571A1 (en) * 2005-08-18 2007-02-22 Smith & Nephew, Plc High strength devices and composites
CN100443065C (zh) * 2006-01-26 2008-12-17 上海交通大学 用于颌面骨缺损修复的复合体系植入体单元
CA2679365C (en) 2006-11-30 2016-05-03 Smith & Nephew, Inc. Fiber reinforced composite material
EP2142353A1 (en) 2007-04-18 2010-01-13 Smith & Nephew PLC Expansion moulding of shape memory polymers
ATE547129T1 (de) 2007-04-19 2012-03-15 Smith & Nephew Inc Multimodale formgedächtnis-polymere
JP5680957B2 (ja) 2007-04-19 2015-03-04 スミス アンド ネフュー インコーポレーテッドＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ，Ｉｎｃ． グラフト固定
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
EP2172189A1 (en) * 2008-10-01 2010-04-07 Novartis AG Pharmaceutical Compositions
EP2323623B1 (en) 2008-08-12 2016-07-27 Novartis AG Pharmaceutical compositions
US9642658B2 (en) 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
WO2010045487A1 (en) * 2008-10-15 2010-04-22 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via internal implants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
US20130071403A1 (en) 2011-09-20 2013-03-21 Vical Incorporated Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
CN104189954B (zh) * 2014-09-19 2017-03-29 中国科学院长春应用化学研究所 一种原位固化组织工程支架及其制备方法
RU2571548C1 (ru) * 2014-12-17 2015-12-20 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук Ветеринарное имплантируемое средство пролонгированного действия (варианты)
WO2017084973A1 (en) 2015-11-16 2017-05-26 Evonik Röhm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
JP2023500506A (ja) 2019-11-04 2023-01-06 アストラゼネカ・アクチエボラーグ 癌を治療するための組み合わせ療法
EP4255357A1 (en) 2020-12-29 2023-10-11 Sino Medical Sciences Technology Inc. Drug eluting stent
EP4608995A1 (en) 2022-10-24 2025-09-03 Memorial Sloan-Kettering Cancer Center Tumour stratification for responsiveness to an immune checkpoint inhibitor
CN120187419A (zh) 2022-10-24 2025-06-20 癌症研究技术有限公司 通过氧化还原状态调节剂使肿瘤对检查点抑制剂敏感
WO2024150017A1 (en) 2023-01-13 2024-07-18 Akrivia Biomedics Limited Method of profiling diseases
NL2037811B1 (en) 2024-05-29 2025-12-12 Univ Oslo Treatment for Cancer
GB202408360D0 (en) 2024-06-11 2024-07-24 Cancer Research Tech Ltd Tumour sensitisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511666A (ja) * 1994-04-08 1997-11-25 アトリックス・ラボラトリーズ・インコーポレイテッド 医療装置で使用する付随的ポリマー系
AU4652596A (en) 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
ES2256898T3 (es) * 1996-12-20 2006-07-16 Alza Corporation Composicion de gel y procedimientos.
UA67754C2 (uk) * 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Also Published As

Publication number Publication date
US8017144B2 (en) 2011-09-13
GT200200242A (es) 2003-06-25
GEP20063951B (en) 2006-10-25
AU2002347502A1 (en) 2003-06-10
JP4903985B2 (ja) 2012-03-28
CN1599598A (zh) 2005-03-23
MA27084A1 (fr) 2004-12-20
AR037462A1 (es) 2004-11-10
PY0229226A (es) 2004-06-01
CA2468703A1 (en) 2003-06-05
ECSP045124A (es) 2004-07-23
EA200400608A1 (ru) 2004-10-28
SV2004001421A (es) 2004-05-07
KR20040062977A (ko) 2004-07-09
HUP0402135A2 (hu) 2005-02-28
NO20042273L (no) 2004-07-14
YU35004A (sh) 2006-08-17
AU2009200125B2 (en) 2012-02-02
KR100629380B1 (ko) 2006-09-29
PA8559001A1 (es) 2003-11-12
JP2005515190A (ja) 2005-05-26
BR0214610A (pt) 2004-09-14
EP1448166A1 (en) 2004-08-25
EA011350B1 (ru) 2009-02-27
CA2468703C (en) 2009-12-29
NZ533115A (en) 2005-12-23
IL161835A0 (en) 2005-11-20
WO2003045351A1 (en) 2003-06-05
AP2004003037A0 (en) 2004-06-30
DOP2002000534A (es) 2003-05-31
ZA200402755B (en) 2005-04-08
PL370085A1 (en) 2005-05-16
HUP0402135A3 (en) 2008-04-28
US20030104031A1 (en) 2003-06-05
MXPA04003723A (es) 2005-04-08
UA76792C2 (uk) 2006-09-15
AP1781A (en) 2007-09-27
HRP20040486A2 (en) 2004-10-31
PE20030581A1 (es) 2003-07-08
OA12731A (en) 2006-06-28
TNSN04096A1 (fr) 2006-06-01
AU2009200125A1 (en) 2009-02-05
TW200300695A (en) 2003-06-16
US20090169595A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
IS7217A (is) Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum
DK1417180T3 (da) Fremstilling af aminopyrimidinforbindelser
IS3027B (is) Hraðuppleysandi samsetning af kalsíum viðtaka-virku efnasambandi
DE60124152D1 (de) Kosmetische zusammensetzungen enthaltend siloxancopolymer-netzwerke
EP1727489A4 (en) BONE GRAFT SUBSTITUTE
DK1351630T3 (da) Implantat til rekonstruktion af led
DK1307181T3 (da) Hidtil ukendte sammensætninger af minoxidil
DK1448044T3 (da) Plantepotte af plastmateriale
DK1393047T3 (da) Selektiv skelnen af planter
IS7007A (is) Kristallaform af asiþrómýsíni
DE602004023302D1 (de) Chirurgisches implantat
FI20010873L (fi) Luuta korvaavat materiaalit
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
DE60315312D1 (de) Arthroplastie-implantat
FI20010694L (fi) Implantti
DK1522539T3 (da) Krystallinsk komposition indeholdende excitalopram
ATE326842T1 (de) Zusammensetzung zur saatgutbehandlung
DK1132570T3 (da) Sammensætninger til syrebehandling af borebrönde
DE60210020D1 (de) Herstellung von Polysulfidzusammensetzungen
DE60230088D1 (de) Prothetisches Implantat
DE60215601D1 (de) Stabile Zusammensetzung
DE60223455D1 (de) Wasserbeständige Polymernetzwerk-Zusammensetzungen
DK1337228T3 (da) Sammensætninger til fjernelse af human cerumen
DE60223962D1 (de) Verwendung Duftstoff zurückhaltender Zusammensetzungen
EP1407780A4 (en) PHARMACEUTICAL, STABLE HEMOSTATIC COMPOSITIONS